Integer Holdings Co. (NYSE:ITGR) Stock Holdings Lifted by QRG Capital Management Inc.

QRG Capital Management Inc. increased its stake in Integer Holdings Co. (NYSE:ITGR) by 3.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 36,938 shares of the medical equipment provider’s stock after buying an additional 1,374 shares during the period. QRG Capital Management Inc.’s holdings in Integer were worth $4,895,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Creative Planning boosted its position in shares of Integer by 22.2% in the 3rd quarter. Creative Planning now owns 9,077 shares of the medical equipment provider’s stock valued at $1,180,000 after purchasing an additional 1,650 shares during the period. First Trust Direct Indexing L.P. acquired a new position in shares of Integer in the third quarter worth about $215,000. New York State Common Retirement Fund increased its position in shares of Integer by 1.0% in the third quarter. New York State Common Retirement Fund now owns 192,411 shares of the medical equipment provider’s stock worth $25,013,000 after acquiring an additional 1,820 shares in the last quarter. James Investment Research Inc. raised its holdings in shares of Integer by 7.2% during the third quarter. James Investment Research Inc. now owns 12,290 shares of the medical equipment provider’s stock valued at $1,598,000 after acquiring an additional 824 shares during the period. Finally, F M Investments LLC lifted its position in shares of Integer by 1.0% in the 3rd quarter. F M Investments LLC now owns 97,164 shares of the medical equipment provider’s stock valued at $12,631,000 after acquiring an additional 925 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Trading Down 0.6 %

Shares of NYSE ITGR opened at $123.01 on Friday. The business has a 50 day simple moving average of $136.85 and a 200 day simple moving average of $132.83. Integer Holdings Co. has a 52 week low of $107.11 and a 52 week high of $146.36. The stock has a market cap of $4.14 billion, a price-to-earnings ratio of 36.61, a PEG ratio of 1.72 and a beta of 1.13. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. On average, research analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Citigroup lifted their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research note on Tuesday, December 3rd. Benchmark lifted their target price on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Finally, Truist Financial increased their price target on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and an average price target of $147.67.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.